MJFF Announces 5 Parkinson’s Clinical Trials in Need of Recruits
Participants are now being recruited for several clinical trials testing investigational treatments for Parkinson’s disease, The Michael J. Fox…
Articles by Marisa Wexler, MS
Upcoming Clinical Trial Will Test Immunosuppressant in Slowing Parkinson’s
An upcoming clinical trial, known as the AZA-PD study, will test whether limiting the activity of the immune system…
FDA Approves Nuplazid for Capsule Sprinkling
The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Nuplazid (pimavanserin)…
Xeomin Approved in Canada to Treat Excessive Drooling, Common in Parkinson’s
Xeomin (incobotulinumtoxinA) has been approved by Health Canada to treat adults with chronic sialorrhea…
Diabetes Medication Glibenclamide May Be Useful for Treating Parkinson’s, Study Suggests
Aggregates of alpha-synuclein alter the electrical activity of dopamine-producing neurons, demonstrating a mechanistic link between two key features of…
Loneliness Linked to Worse Parkinson’s Symptoms, Study Finds
People with Parkinson’s disease who are lonely are more likely to have more severe symptoms and worse quality…
SpeechVive Offers Free, Remote Device-calibration Software During Pandemic
In response to the COVID-19 pandemic, SpeechVive is making remote calibration software and training free for its medical…
Gene Tied to Essential Tremor May Also Be Cause of Early Onset Parkinson’s
Mutations in the gene TNEM4, previously associated with essential tremor, may also be a cause of Parkinson’s disease, at…
PPMI Study Expanding Enrollment
The Parkinson’s Progression Markers Initiative (PPMI), a study sponsored by The Michael J. Fox Foundation, is expanding to…
Impact of Mood Problems Worse on Patients With Longer Disease Course
Mood problems have a greater impact on quality of life among Parkinson’s patients who have had the neurodegenerative disorder…